Japan is no longer a market foreign medical device companies can afford to treat as “difficult […]
Daiichi Sankyo is no longer best understood as a successful Japanese pharma company with a strong […]
Japan is one of the world’s most demanding healthcare markets. It is also one of the […]
The surge I sensed at BioJapan 2025 in October reflects deliberate engineering rather than hype: targeted […]
A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]